These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 31388835)

  • 1. How to Optimize Patient Selection and Device Performance of the Newest Generation Left Ventricular Assist Devices.
    Albert CL; Estep JD
    Curr Treat Options Cardiovasc Med; 2019 Aug; 21(9):48. PubMed ID: 31388835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical and cost-effectiveness of left ventricular assist devices for end-stage heart failure: a systematic review and economic evaluation.
    Clegg AJ; Scott DA; Loveman E; Colquitt J; Hutchinson J; Royle P; Bryant J
    Health Technol Assess; 2005 Nov; 9(45):1-132, iii-iv. PubMed ID: 16303098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implication of Preoperative Existence of Atrial Fibrillation on Hemocompatibility-Related Adverse Events During Left Ventricular Assist Device Support.
    Imamura T; Kinugawa K; Ono M; Kinoshita O; Fukushima N; Shiose A; Matsui Y; Yamazaki K; Saiki Y; Usui A; Niinami H; Matsumiya G; Arai H; Sawa Y
    Circ J; 2019 May; 83(6):1286-1292. PubMed ID: 31019163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3D Morphological Changes in LV and RV During LVAD Ramp Studies.
    Addetia K; Uriel N; Maffessanti F; Sayer G; Adatya S; Kim GH; Sarswat N; Fedson S; Medvedofsky D; Kruse E; Collins K; Rodgers D; Ota T; Jeevanandam V; Mor-Avi V; Burkhoff D; Lang RM
    JACC Cardiovasc Imaging; 2018 Feb; 11(2 Pt 1):159-169. PubMed ID: 28412431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse Hemodynamic Consequences of Continuous Left Ventricular Mechanical Support: JACC Review Topic of the Week.
    Grinstein J; Belkin MN; Kalantari S; Bourque K; Salerno C; Pinney S
    J Am Coll Cardiol; 2023 Jul; 82(1):70-81. PubMed ID: 37380306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Device Management and Flow Optimization on Left Ventricular Assist Device Support.
    Tchoukina I; Smallfield MC; Shah KB
    Crit Care Clin; 2018 Jul; 34(3):453-463. PubMed ID: 29907276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Residual native left ventricular function optimization using quantitative 3D echocardiographic assessment of rotational mechanics in patients with left ventricular assist devices.
    Medvedofsky D; Mor-Avi V; Sayer G; Addetia K; Kruse E; Adatya S; Kim G; Weinert L; Yamat M; Ota T; Jeevanandam V; Uriel N; Lang RM
    Echocardiography; 2018 Oct; 35(10):1606-1615. PubMed ID: 30044511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minimally invasive left ventricular assist device placement.
    Cheng A
    J Vis Surg; 2015; 1():25. PubMed ID: 29075614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
    Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dobutamine stress echocardiography predicts myocardial improvement in patients supported by left ventricular assist devices (LVADs): hemodynamic and histologic evidence of improvement before LVAD explantation.
    Khan T; Delgado RM; Radovancevic B; Torre-Amione G; Abrams J; Miller K; Myers T; Okerberg K; Stetson SJ; Gregoric I; Hernandez A; Frazier OH
    J Heart Lung Transplant; 2003 Feb; 22(2):137-46. PubMed ID: 12581761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left ventricular assist devices: A historical perspective at the intersection of medicine and engineering.
    Goodman D; Stulak J; Rosenbaum AN
    Artif Organs; 2022 Dec; 46(12):2343-2360. PubMed ID: 35929377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The momentum of HeartMate 3: a novel active magnetically levitated centrifugal left ventricular assist device (LVAD).
    Chatterjee A; Feldmann C; Hanke JS; Ricklefs M; Shrestha M; Dogan G; Haverich A; Schmitto JD
    J Thorac Dis; 2018 Jun; 10(Suppl 15):S1790-S1793. PubMed ID: 30034854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Society of Thoracic Surgeons Intermacs database annual report: Evolving indications, outcomes, and scientific partnerships.
    Kormos RL; Cowger J; Pagani FD; Teuteberg JJ; Goldstein DJ; Jacobs JP; Higgins RS; Stevenson LW; Stehlik J; Atluri P; Grady KL; Kirklin JK
    J Heart Lung Transplant; 2019 Feb; 38(2):114-126. PubMed ID: 30691593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical implications of hemodynamic assessment during left ventricular assist device therapy.
    Imamura T; Chung B; Nguyen A; Sayer G; Uriel N
    J Cardiol; 2018 Apr; 71(4):352-358. PubMed ID: 29287808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Society of Thoracic Surgeons Intermacs Database Annual Report: Evolving Indications, Outcomes, and Scientific Partnerships.
    Kormos RL; Cowger J; Pagani FD; Teuteberg JJ; Goldstein DJ; Jacobs JP; Higgins RS; Stevenson LW; Stehlik J; Atluri P; Grady KL; Kirklin JK
    Ann Thorac Surg; 2019 Feb; 107(2):341-353. PubMed ID: 30691584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous ramp right heart catheterization and echocardiography in a ReliantHeart left ventricular assist device.
    Banerjee D; Dutt D; Duclos S; Sallam K; Wheeler M; Ha R
    World J Cardiol; 2017 Jan; 9(1):55-59. PubMed ID: 28163837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
    John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal Hemodynamics During Left Ventricular Assist Device Support Are Associated With Reduced Readmission Rates.
    Imamura T; Jeevanandam V; Kim G; Raikhelkar J; Sarswat N; Kalantari S; Smith B; Rodgers D; Besser S; Chung B; Nguyen A; Narang N; Ota T; Song T; Juricek C; Mehra M; Costanzo MR; Jorde UP; Burkhoff D; Sayer G; Uriel N
    Circ Heart Fail; 2019 Feb; 12(2):e005094. PubMed ID: 30704291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Echocardiographic Evaluation of Hemodynamics in Patients With Systolic Heart Failure Supported by a Continuous-Flow LVAD.
    Estep JD; Vivo RP; Krim SR; Cordero-Reyes AM; Elias B; Loebe M; Bruckner BA; Bhimaraj A; Trachtenberg BH; Ashrith G; Torre-Amione G; Nagueh SF
    J Am Coll Cardiol; 2014 Sep; 64(12):1231-41. PubMed ID: 25236515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left Ventricular Decompression During Speed Optimization Ramps in Patients Supported by Continuous-Flow Left Ventricular Assist Devices: Device-Specific Performance Characteristics and Impact on Diagnostic Algorithms.
    Uriel N; Levin AP; Sayer GT; Mody KP; Thomas SS; Adatya S; Yuzefpolskaya M; Garan AR; Breskin A; Takayama H; Colombo PC; Naka Y; Burkhoff D; Jorde UP
    J Card Fail; 2015 Oct; 21(10):785-91. PubMed ID: 26117282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.